ANDA 90773, held by Wockhardt. Duloxetine Hydrochloride.
As of Nov 16, 2026, ANDA 90773 (Duloxetine Hydrochloride), held by Wockhardt, was not approved, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Jul 6, 2011 | Original application | Tentative approval | None posted |
| Duloxetine Hydrochloride20MG · capsule, delayed release; oral | Duloxetine Hydrochloride | None (tentative approval) |
| Duloxetine Hydrochloride30MG · capsule, delayed release; oral | Duloxetine Hydrochloride | None (tentative approval) |
| Duloxetine Hydrochloride60MG · capsule, delayed release; oral | Duloxetine Hydrochloride | None (tentative approval) |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters